Device Ophthalmology

Crystalens Accommodating Iol (At-52ao)

Payments companies reported to CMS as associated with Crystalens Accommodating Iol (At-52ao). "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$831Kassociated payments (2023-2025)
152clinicians with associated payments
1company reporting

By year

2023 $298K
2024 $279K
2025 $254K

Payments reported as associated with Crystalens Accommodating Iol (At-52ao), per program year, as reported to CMS.

Who makes it

Specialties most often involved

Ophthalmology $691K
Ophthalmic Plastic and Reconstructive Surgery $20K
Cornea and External Diseases Specialist $16K
Internal Medicine $12K
Glaucoma Specialist $11K
Surgery $2,381

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Crystalens Accommodating Iol (At-52ao)

These are the largest totals companies reported as associated with Crystalens Accommodating Iol (At-52ao). They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Steven Kane Venice, FL Ophthalmology $39,702.52
Lisa Nijm Springfield, IL Ophthalmology $35,100.23
Sheri Rowen Newport Beach, CA Ophthalmology $33,065.43
Douglas Katsev Santa Barbara, CA Ophthalmology $33,057.44
Inder Singh Racine, WI Ophthalmology $31,664.92
Steven Silverstein Kansas City, MO Ophthalmology $29,993.95
Francis Mah Pittsburgh, PA $28,167.23
Robert Weinstock Largo, FL Ophthalmology $28,090.60
Neel Desai Largo, FL Ophthalmology $24,298.72
Lisa Feulner Bel Air, MD $24,236.77

Prescribed Crystalens Accommodating Iol (At-52ao)?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.